DOF4.5 Antibody

Shipped with Ice Packs
In Stock

Description

Methodology for Information Verification

A systematic search was conducted across multiple platforms including:

  • Nature Publishing Group (Sources )

  • Thermo Fisher Scientific antibody databases (Sources )

  • National Center for Biotechnology Information repositories (Sources )

  • Kyowa Kirin and Creative Biolabs technical resources (Sources )

No matches were found for "DOF4.5 Antibody" in:

  • Antibody nomenclature databases

  • Structural biology studies

  • Commercial product listings

Analysis of Similar-Sounding Antibodies

Several antibodies with alphanumeric designations were identified but none correlate to "DOF4.5":

Antibody DesignationTarget/FunctionSource
RM4-5Mouse CD4 antigen
1E12PF4/heparin complexes
C#5/C#21DR4/DR5 receptors
MAB5580Mouse F4/80 antigen

Potential Explanations for Missing Data

  1. Nomenclature Issues:

    • May represent an internal laboratory designation not published

    • Could be a typographical error for existing antibodies (e.g., DOF-4 vs. F4/80 )

  2. Development Stage:

    • Preclinical candidates often lack public documentation

    • Discontinued projects may have limited publication history

  3. Proprietary Restrictions:

    • Industry-developed antibodies may be under patent protection

    • Academic collaborations sometimes delay publication

Recommended Verification Steps

  1. Confirm exact spelling/nomenclature with original source

  2. Check regional patent databases (USPTO, EPO, JPO)

  3. Contact antibody development consortia:

    • The Antibody Society

    • International Immunogenetics Information System

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
DOF4.5 antibody; At4g21080 antibody; F7J7.20Dof zinc finger protein DOF4.5 antibody; AtDOF4.5 antibody
Target Names
DOF4.5
Uniprot No.

Target Background

Function
DOF4.5 Antibody targets a transcription factor that binds specifically to a 5'-AA[AG]G-3' consensus core sequence.
Database Links

KEGG: ath:AT4G21080

STRING: 3702.AT4G21080.1

UniGene: At.64194

Subcellular Location
Nucleus.

Q&A

Given the lack of specific information on "DOF4.5 Antibody" in the search results, I will create a general FAQ for researchers on antibodies, focusing on aspects relevant to academic research scenarios. This will include experimental design, data analysis, and methodological considerations.

A:

To evaluate the specificity and sensitivity of an antibody, follow these steps:

  • Specificity: Use Western blotting or immunohistochemistry to test the antibody against known positive and negative controls. Ensure that the antibody binds specifically to the target protein without cross-reacting with other proteins.

  • Sensitivity: Determine the minimum concentration of the target protein that the antibody can detect. This can be done by serial dilution of the target protein in a Western blot or ELISA assay.

  • Controls: Include both positive and negative controls in each experiment to validate the results.

A:

Several techniques are used to validate antibodies:

  • Western Blotting: To check for specificity and sensitivity.

  • Immunohistochemistry (IHC): To assess the antibody's ability to bind to the target protein in tissue samples.

  • ELISA: To quantify the antibody's binding affinity.

  • Flow Cytometry: For cell surface protein detection.

  • Immunoprecipitation (IP): To confirm the antibody's ability to pull down the target protein.

A:

When encountering contradictory data:

  • Re-evaluate Experimental Conditions: Check for differences in sample preparation, antibody concentration, and incubation times.

  • Use Multiple Detection Methods: Validate findings using different techniques (e.g., Western blot and IHC).

  • Statistical Analysis: Apply appropriate statistical tests to determine if observed differences are significant.

  • Literature Review: Compare your results with published studies to identify potential explanations for discrepancies.

A:

To map the epitope recognized by an antibody:

  • Peptide Arrays: Use peptide arrays to identify the specific sequence recognized by the antibody.

  • Mutagenesis Studies: Create point mutations in the target protein and assess the effect on antibody binding.

  • Structural Biology Techniques: Use X-ray crystallography or cryo-EM to visualize the antibody-antigen complex.

A:

When producing antibodies:

  • Immunogen Selection: Choose an immunogen that is representative of the target protein's native structure.

  • Host Selection: Select an appropriate host for immunization (e.g., mice, rabbits).

  • Screening Techniques: Use ELISA or Western blotting to screen hybridoma supernatants for specific antibody production.

  • Purification Methods: Use affinity purification (e.g., protein A or G) to isolate the antibody.

A:

To maintain antibody stability:

  • Storage Conditions: Store antibodies at -20°C or -80°C in a buffer that maintains their stability (e.g., PBS with glycerol).

  • Avoid Freeze-Thaw Cycles: Minimize freeze-thaw cycles to prevent degradation.

  • Concentration and Buffer: Use the recommended concentration and buffer to prevent aggregation or denaturation.

A:

Common issues include:

  • Non-specific Binding: Use blocking agents or optimize antibody concentration.

  • Low Signal: Increase antibody concentration or use a more sensitive detection method.

  • Background Noise: Optimize washing steps or use a different secondary antibody.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.